Accelerating Parkinson’s Disease drug development with federated learning approaches
- DOI
- 10.1038/s41531-024-00837-5
- Published
- 2024-11-21
- Container
- npj Parkinson's Disease
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41531-024-00837-5,
title = {Accelerating Parkinson’s Disease drug development with federated learning approaches},
author = {Amit Khanna and Jamie Adams and Chrystalina Antoniades and Bastiaan R. Bloem and Camille Carroll and Jesse Cedarbaum and Joshua Cosman and David T. Dexter and Marissa F. Dockendorf and Jeremy Edgerton and Laura Gaetano and Erkuden Goikoetxea and Derek Hill and Fay Horak and Elena S. Izmailova and Tairmae Kangarloo and Dina Katabi and Catherine Kopil and Michael Lindemann and Jennifer Mammen and Kenneth Marek and Kevin McFarthing and Anat Mirelman and Martijn Muller and Gennaro Pagano and M. Judith Peterschmitt and Jie Ren and Lynn Rochester and Sakshi Sardar and Andrew Siderowf and Tanya Simuni and Diane Stephenson and Christine Swanson-Fischer and John A. Wagner and Graham B. Jones},
year = {2024},
journal = {npj Parkinson's Disease},
doi = {10.1038/s41531-024-00837-5},
url = {https://doi.org/10.1038/s41531-024-00837-5}
}RIS
TY - JOUR TI - Accelerating Parkinson’s Disease drug development with federated learning approaches AU - Amit Khanna AU - Jamie Adams AU - Chrystalina Antoniades AU - Bastiaan R. Bloem AU - Camille Carroll AU - Jesse Cedarbaum AU - Joshua Cosman AU - David T. Dexter AU - Marissa F. Dockendorf AU - Jeremy Edgerton AU - Laura Gaetano AU - Erkuden Goikoetxea AU - Derek Hill AU - Fay Horak AU - Elena S. Izmailova AU - Tairmae Kangarloo AU - Dina Katabi AU - Catherine Kopil AU - Michael Lindemann AU - Jennifer Mammen AU - Kenneth Marek AU - Kevin McFarthing AU - Anat Mirelman AU - Martijn Muller AU - Gennaro Pagano AU - M. Judith Peterschmitt AU - Jie Ren AU - Lynn Rochester AU - Sakshi Sardar AU - Andrew Siderowf AU - Tanya Simuni AU - Diane Stephenson AU - Christine Swanson-Fischer AU - John A. Wagner AU - Graham B. Jones PY - 2024 JO - npj Parkinson's Disease DO - 10.1038/s41531-024-00837-5 UR - https://doi.org/10.1038/s41531-024-00837-5 ER -
APA
Khanna, A., Adams, J., Antoniades, C., Bloem, B. R., Carroll, C., Cedarbaum, J., Cosman, J., Dexter, D. T., Dockendorf, M. F., Edgerton, J., Gaetano, L., Goikoetxea, E., Hill, D., Horak, F., Izmailova, E. S., Kangarloo, T., Katabi, D., Kopil, C., Lindemann, M., Mammen, J., Marek, K., McFarthing, K., Mirelman, A., Muller, M., Pagano, G., Peterschmitt, M. J., Ren, J., Rochester, L., Sardar, S., Siderowf, A., Simuni, T., Stephenson, D., Swanson-Fischer, C., Wagner, J. A., & Jones, G. B. (2024). Accelerating Parkinson’s Disease drug development with federated learning approaches. npj Parkinson's Disease. https://doi.org/10.1038/s41531-024-00837-5
Source records
- crossref · retrieved 2026-09-27T06:25:41.258Z